Biotech stocks are gaining momentum on M&A activity, cancer drug launches and upcoming autoimmune treatment data.

Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Top 10 foreign healthcare stocks by Seeking Alpha Quant Ratings—see high-conviction pharma/biotech picks like JAZZ and AZN, ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

Growing revenue and broker optimism are boosting confidence. The post 3 reasons why this ASX biotech stock could double in value appeared first on The Motley Fool Australia.

This company has more than one iron in the fire. The post This ASX biotech stock could more than double Canaccord Genuity says appeared first on The Motley Fool Australia.